Skip to main content
. 2022 Dec 10;15:2647–2654. doi: 10.2147/CCID.S395654

Table 1.

Comparison of Outcome Variables Between the Malassezia Folliculitis Positive Group and Malassezia Folliculitis Negative Group in Patients Clinically Diagnosed with Acne Vulgaris (n =320)

Variables MF Positive (n=92) MF Negative (n=228) p-value*
Age, mean (SD), years 23.0(7.7) 26.6(7.5) 0.001
Age < 20 years, n (%) 42(45.6) 52(22.8) <0.001
Male sex, n (%) 32(34.8) 50(21.9) 0.017
Itchy symptom, n (%) 33(35.9) 13(5.7) <0.001
Dandruff, n (%) 29(31.5) 15(6.6) <0.001
Underlying seborrheic dermatitis, n (%) 7(7.6) 10(4.4) 0.245
Disease severity of acne, n (%)
Grade 1, mild 39(42.4) 74(32.5) 0.209
Grade 2, moderate 46(50.0) 138(60.5)
Grade 3, severe 7(7.6) 16(7.0)
Location of acne, n (%)
Forehead 77(83.7) 102(44.7) <0.001
Scalp and hairline 55(59.8) 19(8.3) <0.001
Cheek 71(71.2) 183(80.3) 0.536
Chin 50(54.3) 144(63.2) 0.144
Neck 15(16.3) 13(5.7) 0.002
Upper chest 23(25.0) 6(2.6) <0.001
Upper back 57(62.0) 17(7.5) <0.001
Prior medication used, n (%)
Oral or topical steroid use 10(10.8) 10(4.4) 0.002
Oral antibiotics 4(4.4) 11(4.8) 0.855
Topical clindamycin 36(39.1) 127(55.7) 0.007
Topical benzoyl peroxide 23(25.0) 91(39.9) 0.012
Topical retinoid 2(2.2) 12(5.3) 0.221

Notes: *Chi-square or Fisher’s exact test (categorical data) and independent t-test (numeric data) were used to compare the MF positive and MF negative groups.

Abbreviation: MF, Malassezia folliculitis.